Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00876993
Title Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors All Children’s Hospital Johns Hopkins Medicine


childhood ependymoma

high grade glioma


Bevacizumab + Irinotecan + Temozolomide

Age Groups: child
Covered Countries USA

No variant requirements are available.